baber/WOPTO huggingface dataset:
Patent AU-2014345636-B2 (AU)
Title: Use of an organic-inorganic hybrid material for extracting uranium(VI) from a sulfuric acid aqueous solution, issued notably from the sulfuric leaching of a uranium-bearing ore
Inventor: GRANDJEAN AGNES
IPC: B01J20/00
Filed: 2014-11-06
Granted: 2018-09-06
Abstract: The invention relates to the use of an organic-inorganic hybrid material, including an inorganic solid support on which are grafted the organic molecules having general formula (I), where: x, y and z = 0 or 1, with at least one of x, y and z different from 0; m = 1 to 6; v and w = 0 or 1, with v = 1 when w = 0, and v = 0 when w = 1; if x = 0, R
Patent AU-2014364812-B2 (AU)
Title: Cytotoxic peptides and conjugates thereof
Inventor: GEIERSTANGER BERNHARD
IPC: C07K5/02
Filed: 2014-12-17
Granted: 2017-05-25
Abstract: Disclosed herein are novel cytotoxic peptides of formula (I) as described herein: Formula (I) and the use of such peptides in making immunoconjugates (i.e Antibody Drug Conjugates) Also described herein are immunoconjugates (i.e Antibody Drug Conjugates) comprising such novel cytotoxic peptide linked to an antigen binding moiety, such as an antibody; where such immunoconjugates are useful for treating cell proliferative disorders. The invention further provides pharmaceutical compositions comprising these immunoconjugates, compositions comprising the immunoconjugates with a therapeutic co-agent, and methods to use these immunoconjugates and compositions for treating cell proliferation disorders.
Patent AU-2014389437-B2 (AU)
Title: Method for treating chronic lymphocytic leukemia
Inventor: EASTMAN ALAN R
IPC: A61P35/02
Filed: 2014-04-04
Granted: 2019-06-20
Abstract: The present disclosure provides methods for treating chronic lymphocytic leukemia (CLL) with medicaments useful for same. The medicaments can be pharmaceutical compositions or kits comprising compounds of formula (I) or a salt, solvate or prodrug thereof. Specific compounds of the invention include 2-methyl-7-hydroxy-3-(3,4,5-trimethoxybenzoyl)-6-methoxybenzofuran which is also known as BNC105 and disodium 6-methoxy-2-methyl-3-(3,4,5-trimethoxybenzoyl)benzofuran-7-yl phosphate which is also known as BNC 105P.
Patent AU-2014410129-B2 (AU)
Title: Encryption of fluid cartridges for use with imaging devices
Inventor: NESS ERIK D
IPC: B41J2/175
Filed: 2014-10-31
Granted: 2018-03-08
Abstract: Encryption of fluid cartridges for use with imaging devices is disclosed herein. One disclosed apparatus includes a memory of a fluid cartridge comprising a plurality of sequential bits, where the plurality of sequential bits are written to the memory after the plurality of sequential bits are transformed based on scrambling bits of the plurality of sequential bits, and a memory interface of the fluid cartridge to enable access to the memory to authenticate the fluid cartridge.
Patent AU-2014413131-B2 (AU)
Title: Method to prioritize random access with preamble coding
Inventor: ZHOU CHAN
IPC: H04W16/14
Filed: 2014-12-03
Granted: 2018-08-09
Abstract: The present invention provides a Random Access (RA) method 200 and a base station, a terminal device and a system participating in carrying out the RA method 200. In the RA method 200, at least one of a plurality of terminal devices 301 transmits a resource request with one or more preambles to a base station 302 during one RA time slot. Thereby, each terminal device 301 is configured to combine more preambles for transmitting a resource request having a higher priority level and fewer preambles for transmitting a resource request having a lower priority level. The base station 302 detects a priority level of the at least one resource request based on the number of preambles in the at least one resource request. Finally, the base station 302 assigns uplink resources according to the at least one resource request and the at least one priority level.
Patent AU-2015200826-B2 (AU)
Title: Safeguarding measures for a closed-loop insulin infusion system
Inventor: KEENAN DESMOND BARRY
IPC: G06F19/00
Filed: 2015-02-19
Granted: 2016-06-09
Abstract: SAFEGUARDING MEASURES FOR A CLOSED-LOOP INSULIN INFUSION SYSTEM Processor-implemented methods of controlling an insulin infusion device for a user are provided here. A first method obtains a current insulin on board (JOB) value that estimates active insulin in the user, and compensates a calculated insulin infusion rate in response to the obtained IOB value. A second method supervises the operation of a glucose sensor by obtaining and processing insulin-delivered data and glucose sensor data for the user. An alert is generated if the second method determines that a current glucose sensor value has deviated from a predicted sensor glucose value by at least a threshold amount. 9705191_1
Patent AU-2015203518-B2 (AU)
Title: Carbon dioxide capturing system and method of operating the same
Inventor: UDATSU MITSURU
IPC: C01B32/50
Filed: 2015-06-25
Granted: 2016-09-29
Abstract: In one embodiment, a carbon dioxide capturing system includes an absorber to discharge an absorption liquid having 5 absorbed carbon dioxide, a regenerator to discharge the absorption liquid having released the carbon dioxide, a first line to introduce the absorption liquid discharged from the absorber to the regenerator, a second line to introduce the absorption liquid discharged from the regenerator to the absorber, and a heat 10 exchanger to exchange heat between absorption liquids flowing in the first and second lines. The system further includes a bypass line to branch from the first line between the absorber and the heat exchanger and introduce the absorption liquid to the regenerator without passing through the heat exchanger, a valve 15 on the bypass line, an instrument to measure a value indicating a state of the regenerator, and a controller to control a degree of opening of the valve based on the measured value. - - - - - - - - - - - - - - - - - - - H- N N CN C) 10u1 10 C%4 caN
Patent AU-2015257496-B2 (AU)
Title: Glycolipid containing compositions for use in the treatment of tumours
Inventor: GALILI URI
IPC: A61K31/7032
Filed: 2015-05-08
Granted: 2019-08-15
Abstract: The invention relates to pharmaceutical compositions comprising α-Gal BOEL for use in treating patients with tumours. The invention also relates to methods of treating tumours using said compositions. The invention discloses that following intratumoural injection of α- Gal BOEL, binding of the natural anti-Gal antibody to de novo expressed tumoural α-Gal epitopes induces inflammation resulting in an anti-Gal antibody mediated opsonization of tumour cells and their uptake by antigen presenting cells. These antigen presenting cells migrate to draining lymph nodes and activate tumour specific T cells thereby converting the treated tumour lesions into in situ autologous tumour vaccines. This therapy can be applied to patients with multiple lesions and in neo-adjuvant therapy to patients before tumour resection. In addition to the regression and/or destruction of the treated tumour, such a vaccine will help in the immune mediated destruction of micrometastases that are not detectable during the removal of the treated tumour. The invention further teaches the enhancement of anti-tumour α-Gal BOEL treatment by the use of antibodies that inhibit the activity of immunological checkpoints molecules.
Patent AU-2015264879-B2 (AU)
Title: Extracranial Implantable Devices, Systems and Methods for the Treatment of Neuropsychiatric Disorders
Inventor: COOK IAN A
IPC: A61N1/00
Filed: 2015-12-03
Granted: 2018-03-08
Abstract: EXTRACRANIAL IMPLANTABLE DEVICES, SYSTEMS AND METHODS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS The present disclosure relates to methods, devices and systems used for the treatment of neurological disorders via stimulation of the superficial elements of the trigeminal nerve ("TNS"). More specifically, minimally invasive methods of stimulation of the superficial branches of the trigeminal nerve located extracranially in the face, namely the supraorbital, supratrochlear, infratrochlear, auriculotemporal, zygomaticotemporal, zygomaticoorbital, zygomaticofacial, nasal, infraorbital, and mentalis nerves (also referred to collectively as the superficial trigeminal nerve) are disclosed herein. Systems and devices configured for therapeutic stimulation of the branches of the trigeminal nerves, such as the superficial trigeminal nerve, and their methods of application are also described.
Patent AU-2015264956-B2 (AU)
Title: Anchorage devices comprising an active pharmaceutical ingredient
Inventor: MCJAMES WILLIAM
IPC: A61L31/10
Filed: 2015-12-07
Granted: 2017-03-09
Abstract: TYRX 3.4-010 An anchorage device 100 comprising a mesh substrate 124 coupled to an implantable medical device 120 is disclosed, where the mesh substrate has a coating 120 comprising a polymer, and the mesh further comprises at least one active pharmaceutical ingredient. The active pharmaceutical agent is designed to elute from the device over time. The mesh substrate can be configured to reduce the mass of the anchorage device such that tissue in-growth and/or scar tissue formation at the treatment site is reduced. In some embodiments, the mesh substrate can be formed with a mesh having a low areal density. In some embodiments, the mesh substrate can include one or more apertures or pores to reduce the mass of the substrate. -60-
Patent AU-2015267099-B2 (AU)
Title: Use of eribulin in the treatment of cancer
Inventor: ASANO MAKOTO
IPC: A61K33/243
Filed: 2015-05-27
Granted: 2020-08-27
Abstract: The invention features methods and kits for use in treating cancer in a patient in need thereof by administering eribulin or a pharmaceutically-acceptable salt thereof (e.g., eribulin mesylate) prior to a second agent.
Patent AU-2015275259-B2 (AU)
Title: Arthroscopic Bone Transplanting Procedure, and Medical Instruments Useful Therein
Inventor: OREN RAN
IPC: A61B17/17
Filed: 2015-12-22
Granted: 2017-01-05
Abstract: Described is an arthroscopic bone transplanting procedure for transplanting a section of a first bone to a second bone. The described procedure is particularly useful for the treatment of anterior shoulder instability, where the first bone is the coracoid and the second bond is the glenoid. Also described is a kit of medical instruments particularly useful in such a procedure.
Patent AU-2015279205-B2 (AU)
Title: Fire extinguishing system
Inventor: ERNFJALL JOHNNY
IPC: A62C35/68
Filed: 2015-06-25
Granted: 2019-09-19
Abstract: The present invention relates to a fire extinguishing system comprising a fire extinguishing medium container (3), a first (5) and second (7) fire extinguishing sub-systems, and a valve assembly (9) fluidly connecting the fire extinguishing medium container (3) to each of the first (5) and second (7) fire extinguishing sub-systems. The fire extinguishing system (1) further comprises a first and a second detection conduit arrangement (19, 21) connected to the valve assembly (9) and arranged to activate the fire extinguishing system (1), wherein the valve assembly (9) comprises a valve chamber (33), a valve member (35) being movably arranged in the valve chamber (33), the valve member (35) having: i) a first force receiving surface (45) arranged to be subjected to a first force (F
Patent AU-2015289442-B2 (AU)
Title: Managing lineage information
Inventor: BACH EDWARD
IPC: G06F9/44
Filed: 2015-07-20
Granted: 2019-07-11
Abstract: Managing lineage information includes: receiving lineage information representing one or more lineage relationships among two or more data processing programs and two or more logical datasets; receiving one or more runtime artifacts, each runtime artifact including information related to a previous execution of a data processing program of the two or more data processing programs; and analyzing the one or more runtime artifacts and the lineage information to determine one or more candidate modifications to the lineage information.
Patent AU-2015312886-B2 (AU)
Title: Pyrazolothiazole compound and medicine
Inventor: SHIBA YOSHINOBU
IPC: A61P35/00
Filed: 2015-09-02
Granted: 2020-02-06
Abstract: The purpose of the present invention is to provide a compound having an exceptional JAK1 inhibitory effect. Examples of the present invention include pyrazolothiazole compounds represented by general formula [I], and pharmacologically acceptable salts thereof. Compounds of the present invention have JAK1 inhibitory activity. Given this JAK1 inhibitory activity, compounds of the present invention also have an immunosuppressive effect (against, e.g., rheumatoid arthritis, inflammatory bowel disease, psoriasis, vasculitis), an anti-inflammatory effect (against, e.g., bronchial asthma, chronic obstructive pulmonary disease, eosinophilic sinusitis, nasal polyps), an antiproliferative effect, and the like.
Patent AU-2015333912-B2 (AU)
Title: Light sensor assembly
Inventor: WEBER RONALD MARTIN
IPC: F21W131/103
Filed: 2015-10-07
Granted: 2018-11-15
Abstract: A light sensor assembly (100) includes a base (110) configured to be fixedly mounted to a housing (102) of a light fixture (104). The base holds contacts (130) configured to be electrically connected to terminals of the light fixture. A photocell module (132) is provided on the base and includes a photocell (106) electrically connected to the contacts. A sensor lid (112) is coupled to the base. The sensor lid has a lightpipe (114) directing light from an exterior of the sensor lid to the photocell. The sensor lid is variably positionable at different angular positions relative to the base to change an orientation of the lightpipe relative to the photocell.
Patent AU-2015341922-B2 (AU)
Title: Polypeptides having serine protease activity and polynucleotides encoding same and their application in animal feed
Inventor: HOFF TINE
IPC: C12N9/52
Filed: 2015-11-03
Granted: 2021-06-24
Abstract: The present invention relates to animal feed or animal feed additives comprising polypeptides having protease activity and uses thereof. Specifically, the proteases are serine S1 proteases from Janibacter, Terracoccus and Knoellia, all belonging to the family
Patent AU-2015367187-B2 (AU)
Title: Techniques of synchronizing communications of gaming devices for shared gaming activities
Inventor: MORROW JAMES WILLIAM
IPC: G07F17/32
Filed: 2015-02-11
Granted: 2021-05-27
Abstract: A method for synchronizing a casino game playable at a plurality of gaming devices is provided. The method includes receiving, by a server having at least one processor, an indication of a wager from at least one of the plurality of gaming devices, determining, by the server, a schedule for at least one jackpot of the casino game based at least in part on the received indication of the wager, and sending, by the server, the schedule for the at least one jackpot of the casino game to at least a first gaming device and a second gaming device, the sending including sending the schedule to the first gaming device through wired communication channels, and sending the schedule to the second gaming device through at least one wireless communication channel.
Patent AU-2015410466-B2 (AU)
Title: Materials that shrink in one dimension and expand in another dimension
Inventor: SONG XUEDONG
IPC: A61L15/24
Filed: 2015-09-29
Granted: 2020-09-10
Abstract: A substrate includes a double-network polymer system including a cross-linked, covalently-bonded polymer and a reversible, partially ionicly-bonded polymer, wherein the substrate has a moisture level less than or equal to 15 percent of the total weight of the substrate, and wherein the substrate includes a latent retractive force. A method for manufacturing a substrate includes producing a double-network hydrogel including a cross-linked, covalently-bonded polymer and a reversible, ionicly-bonded polymer; elongating by force the double-network hydrogel in at least one direction; dehydrating while still elongated the double-network hydrogel to form a substantially-dehydrated double-network polymer system; and releasing the force to produce the substrate.
Patent AU-2016203214-B2 (AU)
Title: Method of generating reconstructed block
Inventor: OH SOO MI
IPC: H04N19/593
Filed: 2016-05-17
Granted: 2018-01-18
Abstract: A method of generating a reconstructed block, the method comprising: deriving intra prediction mode for an intra prediction unit using 3 intra prediction modes which determined by a left and an above intra prediction modes of the prediction unit; determining a size of a current block using transform size information; generating a prediction block of the current block using the intra prediction mode of the prediction unit; generating a residual block of the current block; and generating a reconstructed block using the prediction block and the residual block, wherein the size of the current block is equal to or less than the prediction unit, and sizes of the prediction block, the residual block and the reconstructed block are equal to a size of a transform unit, wherein the transform size information includes one or more flags indicating for splitting transform unit (splittu-flag), wherein generating a residual block of the current block comprises: generating a quantization block by inversely scanning quantization coefficient information using an inverse-scanning pattern which is determined based on the intra prediction mode and the size of the current block; and generating the residual block by inversely quantizing the quantization block using a quantization parameter and by inversely transforming the inversely quantized block, wherein the quantization parameter is generated using quantization parameter predictor and differential quantization parameter, and wherein, when both of a left and an above quantization parameters are available, the quantization parameter predictor is generated using the left and the above quantization parameters, and, when only one of the left and the above quantization parameters is available, the quantization parameter predictor is generated using the available quantization parameter and a previous quantization parameter.
Patent AU-2016203871-B2 (AU)
Title: Wearable automatic injection device
Inventor: ANDERSON PHILIP D
IPC: A61M5/142
Filed: 2016-06-09
Granted: 2017-12-21
Abstract: WEARABLE AUTOMATIC INJECTION DEVICE A wearable automatic injection device (3100) free of a battery for administering a therapeutic agent to a patient, the wearable automatic injection device (2600) comprising: a housing (3102) comprising a patient contact portion including a retraction trigger configured to contact the patient, the retraction trigger responsive to a change of state of the wearable automatic injection device (3100) from an administration state to a post-administration state; an administration assembly moveably disposed in the housing (3102) holding an administration interface configured to administer the therapeutic agent to the patient, the administration assembly moveable between a retracted position in which the administration interface does not protrude outside the housing (3102) and an extended position in which the administration interface protrudes outside the housing (3102); a vessel provided in the housing (3102) configured to hold the therapeutic agent; a plunger actuation mechanism moveably disposed in the vessel configured to eject the therapeutic agent from the vessel into the administration assembly; and a retraction mechanism (2810) configured to automatically retract the administration assembly from the extended position in the administration state to the retracted position in the post-administration state upon triggering by the retraction trigger.
Patent AU-2016233216-B2 (AU)
Title: Systems and methods for heart valve therapy
Inventor: GANESAN KAVITHA
IPC: A61F2/86
Filed: 2016-03-17
Granted: 2020-08-20
Abstract: Prosthetic mitral valves described herein can be deployed using a transcatheter mitral valve delivery system and technique to interface and anchor in cooperation with the anatomical structures of a native mitral valve. This document describes prosthetic heart valve designs and techniques to manage blood flow through the left ventricular outflow tract. For example, this document describes prosthetic heart valve designs and techniques that reduce or prevent obstructions of the left ventricular outflow tract that may otherwise result from systolic anterior motion of an anterior leaflet of the native mitral valve.
Patent AU-2016236466-B2 (AU)
Title: Method for identification of user's interaction signature
Inventor: ARMANDO MARCO
IPC: G06F21/31
Filed: 2016-03-15
Granted: 2021-06-17
Abstract: Method for identification of a interaction signature of a user, comprising the flowing steps of: acquisition of a direct data (10), acquisition of an indirect data (20), acquisition and mapping of the environment (30), to obtain an interaction data set characterized in that the method comprising further steps of establishing an interaction space comprising representation (50) of characteristics of an interaction build upon interaction data set; searching through an interaction space historic data for a pattern of characteristics of an interaction to identify a user, or storing interaction data in an interaction space for future identification.
Patent AU-2016262240-B2 (AU)
Title: Container sealing member, and method for producing same
Inventor: WEI SE HWANG
IPC: B65D77/20
Filed: 2016-04-18
Granted: 2019-04-18
Abstract: Disclosed is a container sealing member with excellent heat resistance, openability and sealability. The container sealing member comprises: an upper layer on which an opening tab is formed; and a lower layer which is thermally bonded to an aluminum foil and the container, wherein the upper layer comprises: a first partial opening tab and a second partial opening tab; a first opening induction cutting band and a second opening induction cutting band which are connected to the first and second partial opening tabs and are formed along the inner circumferential surface of an inlet of the container so that the upper layer and the lower layer can be circumferentially opened along the inner circumferential surface of the inlet of the container when the first and second partial opening tabs are gripped and pulled; and a first cut line and a second cut line, wherein the upper layer is separated from the first and second opening induction cutting bands by the first and second cut lines, and the upper layer is thermally bonded to a lip of the container at the outer side of the first and second opening induction cutting bands.
Patent AU-2016357609-B2 (AU)
Title: Method for producing psicose from fructose-containing substrate
Inventor: KWON SOUN GYU
IPC: C12N15/77
Filed: 2016-11-16
Granted: 2020-03-12
Abstract: The present invention relates to: a method for obtaining, with high productivity, a psicose-containing product at an industrial scale within a short time from a fructose-containing substrate by means of an immobilization reaction using a biocatalyst for producing psicose; and a method for preparing a liquid or powdery psicose by isolating a psicose-containing product obtained by the method, and for continuously preparing psicose by putting the by-products of the isolation step into a process of producing a psicose-containing product.
Patent AU-2016379389-B2 (AU)
Title: Encapsulating polymers and selective activation thereof
Inventor: DE STEFANO GUIDO
IPC: C09K8/32
Filed: 2016-12-22
Granted: 2019-08-29
Abstract: Wellbore strengthening compositions and methods of use are disclosed herein, where the wellbore strengthening compositions may include a base fluid and a plurality of hydrogel particles or a plurality of core-shell particles suspended in the base fluid.